PharmaCyte Biotech, Inc. (PMCB) › RevenuePharmaCyte Biotech, Inc. (PMCB) — RevenueAnnual figures by fiscal year, from SEC filings.2011: $126.0K2012: $66.6K2013: $12.2K2014: $02015: $02016: $02017: $02018: $02019: $02020: $02021: $02022: $02023: $02024: $02025: $0$02011Revenue (USD)2025Fiscal YearRevenueChange YoY2025$0—2024$0—2023$0—2022$0—2021$0—2020$0—2019$0—2018$0—2017$0—2016$0—2015$0—2014$0-100.0%2013$12.2K-81.7%2012$66.6K-47.2%2011$126.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share